What Is the AOD9604 Peptide?
AOD9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), corresponding to residues 176-191 - the segment identified in research as the "lipolytic domain" of the GH molecule. The fragment is modified by the addition of a tyrosine residue at the N-terminus (a Tyr-modified hGH 176-191), a change made to improve the stability and consistency of the sequence.
AOD9604 was originally developed on the scientific premise that the fat-metabolizing activity of growth hormone could be isolated from its growth-promoting activity. This makes it a compound of enduring interest as a research tool for studying "lipolysis-only" GH-derived activity. Preclinical investigation has focused on adipocyte metabolism in cell culture and rodent models. It is important to frame AOD9604 strictly in preclinical and mechanistic terms; large human obesity trials did not establish definitive weight-loss efficacy, and Amino Labs supplies it exclusively as a research compound, not for human or animal use.
Recommended Products
Mechanisms and Pathways Researchers Explore
AOD9604 is studied primarily for its lipolytic (fat-breakdown) and anti-lipogenic (reduced fat synthesis) effects in adipose tissue. The research premise is that it reproduces the fat-metabolizing portion of GH’s action without engaging the full hormone’s other systemic effects.
A defining finding in the research literature is that, unlike full-length growth hormone, AOD9604 does not appear to raise IGF-1 levels and does not adversely affect blood glucose or insulin sensitivity in study models. In other words, it is investigated as a compound that dissociates lipolytic action from the growth-factor and glucose-metabolic actions of GH. It is generally understood not to act through the GH receptor in the classic growth-signaling manner; instead, the mechanism is framed around adipocyte metabolism.
Areas of preclinical research investigation include:
- Adipose-tissue metabolism - the historical focus, examining stimulation of lipolysis and inhibition of lipogenesis in fat cells.
- Metabolic dissociation studies - using AOD9604 as a tool precisely because it does not replicate GH’s IGF-1 and glucose effects.
- Cartilage and regenerative research - explored in chondrocyte and cartilage-repair contexts, sometimes in combination with agents such as hyaluronic acid.
A beta-3 adrenergic receptor contribution to the lipolytic effect has been proposed but remains debated in the literature and should be regarded as unsettled. Researchers often study AOD9604 alongside other metabolic research compounds such as MOTS-c to compare distinct energy-metabolism pathways.
Research Handling, Storage, and Quality Considerations
AOD9604 is supplied as a lyophilized powder. For long-term stability, the freeze-dried material is typically stored frozen at -20°C or colder, sealed and protected from light and moisture. Because peptides are hygroscopic, keeping the vial desiccated is a standard laboratory practice.
When preparing the compound for research, it is reconstituted with sterile or bacteriostatic water. Reconstituted solutions are generally refrigerated at 2-8°C and used within a limited timeframe, as peptides in solution degrade faster than the dry lyophilate. To preserve integrity, researchers should aliquot before freezing and avoid repeated freeze-thaw cycles.
Purity and sourcing are critical to reproducible research. Amino Labs provides AOD9604 at 99%+ HPLC-verified purity, lyophilized and third-party tested, with supporting batch documentation. As a Canadian-owned supplier shipping across Canada via Purolator, we emphasize analytical transparency. Comparing metabolic fragments, some researchers reference the broader GHRH analog class; regardless of compound, verified purity ensures that study observations reflect the peptide itself rather than contaminants.